Gabelli & Co Investment Advisers’s Checkpoint Therapeutics CKPT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,019,750	Closed	-$4.12M	–	267
2025 Q1	$4.12M	Buy	+1,019,750	New	+$3.4M	0.62%	46

Gabelli & Co Investment Advisers's CKPT Position: Q2 2025 in Review

Gabelli & Co Investment Advisers sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 1,019,750 shares — an estimated $4.12M sold.

Gabelli & Co Investment Advisers first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $4.12M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Gabelli & Co Investment Advisers reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 1,019,750 Checkpoint Therapeutics shares in Q2 2025, an estimated $4.12M.
Gabelli & Co Investment Advisers first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Checkpoint Therapeutics position peaked at $4.12M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.